Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Vericel Community
NasdaqGM:VCEL Community
1
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Community Investing Ideas
Vericel
Popular
Undervalued
Overvalued
Vericel
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Expanding Regenerative Therapies Will Open New Market Horizons
Key Takeaways Expanding surgeon network, label extensions, and rising regenerative therapy demand are fueling market penetration, revenue growth, and long-term diversification opportunities. Operational improvements and strong payer acceptance are supporting margin expansion, increased profitability, and stable long-term financial performance.
View narrative
US$53.88
FV
32.7% undervalued
intrinsic discount
23.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
VCEL
VCEL
Vericel
Your Fair Value
US$
Current Price
US$36.28
37.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-29m
618m
2015
2018
2021
2024
2025
2027
2030
Revenue US$618.1m
Earnings US$17.6m
Advanced
Set Fair Value